United States FDA: The clinical benefits of NovoCure cancer treatment devices are still unclear
2026-11-09 20:13:31
According to CoinMeta, the U.S. Food and Drug Administration (FDA) stated in its review that the clinical benefits of the cancer treatment devices under NovoCure are not yet clear. As a result, the company's stock price fell by 5% before the market opened.
Source:Internet
This content is for market information only and does not constitute investment advice.
Follow WalletJYS official accounts to stay updated

Hot Articles
Refresh

Coinbase Is the exchange safe? How can beginners in 2026 download and register?
3h ago

$TRUMP Hits New Low, Down 30% , Can It Hold?
6h ago

XRP Price Outlook: Can XRP Hit $1.87 in November?
11-06 11:51

What Are the Advantages of RWA? Top 5 Benefits
11-05 17:04

Bitcoin November Price: Can It Hit $90,000?
11-02 13:02



